StockSelector.com
  Research, Select, & Monitor Tuesday, July 17, 2018 1:31:09 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$20.19($.31)(1.51%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 6538 out of 7057 stocks based on 6 positive rankings and 8 negative rankings.

Positive Rankings
Estimated Revenue Growth
Aclaris Therapeutics rank is 17
Debt-to-Equity
Aclaris Therapeutics rank is 127
PEGValue
Aclaris Therapeutics has a PEG Value of $21.45. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 4.61% in the next year. Among companies with a PEG Value above the current stock price, Aclaris Therapeutics is ranked 552.
Low Put/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.63 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 1350.
10 Day Gain
Aclaris Therapeutics rank is 1505
Up EPS Surprise
Aclaris Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Price-to-Sales
Aclaris Therapeutics rank is 66
Negative Net Margin
Aclaris Therapeutics rank is 94
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Aclaris Therapeutics is ranked 546.
High vPut/Call
Aclaris Therapeutics has a high Put/Call ratio of 1.64 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 568.
Negative ROA
Aclaris Therapeutics rank is 768
Negative ROE
Aclaris Therapeutics rank is 786
Price-to-Book
Aclaris Therapeutics rank is 1811
90 Day Loss
Aclaris Therapeutics rank is 1961







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.